It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
"You Are Not Alone" Co-inventorship Requirements Further Clarified in Germany
-
Patent case: Judgment no. 2843/2020, Spain
-
Swiss Federal Supreme Court clarifies consequences of amendment of patent claim under the former Patent Act
-
(Cross-border) jurisdiction, (Indirect) infringement, Case Law, European Union, Injunction, Procedure
Realchemie v. Bayer, European Court of Justice, 18 October 2011
-
Patent case: Ruling of Barcelona Court of Appeal of 13 April 2018, Spain
-
Spanish Supreme Court clarifies that “problem & solution approach” is not legal doctrine
-
A Unified Patent Court with austrian judges only?
-
Barcelona Courts approve Trade Secrets Protocol that may indirectly impact patent cases
-
UPC: Why has the Preparatory Committee thrown expressions of interest sent by Spanish candidate judges into the bin?
-
Esomeprazole – process patent, Bailiff’s Court Frederiksberg (Højesteret), 28 February 2011